• News
  • Video
  • Prices
  • Research
  • Events
  • Data & Indices
  • More
  • Sponsored
    Sign In
    Sign Up
Loading chart...


About
  • About Us
  • Masthead
  • Careers
  • Blog
  • Investor Relations
Contact
  • Contact Us
  • Accessibility
  • Advertise
  • Media Kit
  • Sitemap
  • System status
Newsletters
  • CoinDesk Headlines
  • Crypto Daybook Americas
  • State of Crypto
  • Crypto for Advisors
  • Crypto Long & Short
News
  • Markets
  • Finance
  • Tech
  • Policy
  • Focus
Videos
  • CoinDesk Daily
  • Editor's Picks
  • Shorts
  • Spotlight
Podcasts
  • CoinDesk Podcast Network
  • Markets Outlook
  • Gen C
Cryptocurrencies
  • Latest crypto prices
  • Trending
  • Bitcoin (BTC)
  • Ethereum (ETH)
  • Hyperliquid (HYPE)
  • XRP
  • Solana (SOL)
Data & Indices
  • Market Data
  • Index Offering
  • API
  • Research Insights
  • Documentation and Governance
Events
  • CoinDesk: Policy & Regulation
  • Webinars
Sponsored
  • Thought Leadership
  • Press Releases
  • Advertise with CoinDesk
Research
  • Research Hub
  • Exchange Benchmark

EthicsPrivacyTerms of UseCookie SettingsDo Not Sell My InfoBug Bounty Program
X icon
© 2026 CoinDesk, Inc.

Disclosure & Polices: CoinDesk is an award-winning media outlet that covers the cryptocurrency industry. Its journalists abide by a strict set of editorial policies. CoinDesk has adopted a set of principles aimed at ensuring the integrity, editorial independence and freedom from bias of its publications. CoinDesk is part of Bullish (NYSE:BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services. Bullish owns and invests in digital asset businesses and digital assets and CoinDesk employees, including journalists, may receive Bullish equity-based compensation.

CD20$2,143.82CD20 up 0.11 percent0.11%BTC$77,348.85BTC up 0.21 percent0.21%ETH$2,393.63ETH down 0.87 percent0.87%XRP$1.35XRP up 0.14 percent0.14%SOL$99.72SOL up 0.13 percent0.13%
Prices > COR
CORCOR
$337.06Up 1.84 percent, +$6.081.84%($6.08)
As of today at 12:56 PM ET

Key Stats

Market Cap$61.752B
Volume (24h)524,235
Day's Range$330.62-$337.81
52-Week Range$244.82-$377.54
PE Ratio85.33
EPS3.95
Net Income (FY)$1.57B
Revenue (FY)$321.33B

About Cencora, Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Website
cencora.com
Industry
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Full-time Employees
51,000
Headquarters
CONSHOHOCKEN
IPO Date
Apr 04, 1995
Loading chart...
24 hours5 days1 monthYTD1 yearAll time
Up 1.84 percent1.84%
Up 4.93 percent4.93%
Up 8.26 percent8.26%
Down 0.88 percent0.88%
Up 15.58 percent15.58%
Up 30265.32 percent30265.32%

Similar Stocks

S
S&P 500 ETFSPY
$765.12
Up 0.44 percent0.44%($3.34)
BullishBLSH
$32.61
Down 1.36 percent1.36%($0.45)
Coinbase Global IncCOIN
$174.88
Down 1.10 percent1.10%($1.94)
Circle Internet GroupCRCL
$88.80
Down 0.76 percent0.76%($0.68)

Dernières COR Nouvelles

Beat the Market the Zacks Way: Accelerant, Insight, General Mills in Focus
avant-hierPositif
(opens in a new tab)

Beat the Market the Zacks Way: Accelerant, Insight, General Mills in Focus

18 mai 2026, 2:53 p.m. ETNégatif(opens in a new tab)

COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm

4 févr. 2026, 11:32 a.m. ETNeutre(opens in a new tab)

Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss

23 janv. 2026, 11:00 a.m. ETNeutre(opens in a new tab)

Comparator Drug Sourcing Market to Reach USD 2.72 Billion by 2033, Driven by Rising Global Clinical Trials and Outsourcing Trends – SNS Insider

12 janv. 2026, 9:00 a.m. ETNeutre(opens in a new tab)

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

15 déc. 2025, 9:09 a.m. ETNeutre(opens in a new tab)

Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback

5 déc. 2025, 8:00 a.m. ETNeutre(opens in a new tab)

Iterum Therapeutics Provides Business Update